• Fabien Praz, Friedhelm Beyersdorf, Kristina Haugaa, and Bernard Prendergast.
• University Hospital Bern Inselspital, University of Bern, Bern, Switzerland. Electronic address: fabien.praz@insel.ch.
• Lancet. 2024 Apr 20; 403 (10436): 157615891576-1589.

AbstractValvular heart disease is common and its prevalence is rapidly increasing worldwide. Effective medical therapies are insufficient and treatment was historically limited to the surgical techniques of valve repair or replacement, resulting in systematic underprovision of care to older patients and those with substantial comorbidities, frailty, or left ventricular dysfunction. Advances in imaging and surgical techniques over the past 20 years have transformed the management of valvular heart disease. Better understanding of the mechanisms and causes of disease and an increasingly extensive and robust evidence base provide a platform for the delivery of individualised treatment by multidisciplinary heart teams working within networks of diagnostic facilities and specialist heart valve centres. In this Series paper, we aim to provide an overview of the current and future management of valvular heart disease and propose treatment approaches based on an understanding of the underlying pathophysiology and the application of multidisciplinary treatment strategies to individual patients.Copyright © 2024 Elsevier Ltd. All rights reserved.

22 keywords...

hide…